圖1 光學(xué)顯微鏡觀察顯示,腫瘤組織由形態(tài)一致的圓形細(xì)胞組成 HE染色 ×200 圖2 光學(xué)顯微鏡觀察顯示,腫瘤細(xì)胞胞質(zhì)彌漫性表達(dá)Syn 免疫組化染色(EnVision二步法) ×200Figure 1 Optical microscopy showed the tumor was composed of monotonous round cells. HE staining × 200 Figure 2 Optical microscopy showed Syn was positive in the cytoplasm of tumor cells. Immunohistochemical staining (EnVision) ×200
2017年WHO內(nèi)分泌器官腫瘤分類將下丘腦-垂體區(qū)域的腦室外神經(jīng)細(xì)胞瘤(WHOⅡ級)定義為鞍區(qū)神經(jīng)細(xì)胞瘤。發(fā)病率不詳,已報(bào)道的發(fā)病年齡為23 ~56 歲,臨床均表現(xiàn)為與垂體功能障礙無關(guān)的視野缺損。組織學(xué)形態(tài),腫瘤組織由纖維和血管間質(zhì)內(nèi)形態(tài)一致伴神經(jīng)元分化的圓形細(xì)胞組成(圖1),胞核染色質(zhì)呈“椒-鹽”狀;腫瘤細(xì)胞呈單一片狀排列,其間被神經(jīng)氈背景分隔;可見神經(jīng)節(jié)或神經(jīng)節(jié)樣細(xì)胞。預(yù)后不良患者的非典型組織學(xué)特征包括壞死、微血管增生和核分裂活性增加。免疫組化染色,腫瘤細(xì)胞胞質(zhì)彌漫性表達(dá)突觸素(Syn,圖2),神經(jīng)元核抗原(NeuN)和嗜鉻素A(CgA)等神經(jīng)元或神經(jīng)內(nèi)分泌標(biāo)志物。